{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:48:54Z","timestamp":1789858134563,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T00:00:00Z","timestamp":1405641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10067-014-2744-6","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T03:29:36Z","timestamp":1405567776000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Safety and efficacy of etanercept in children with the JIA categories extended oligoarthritis, enthesitis-related arthritis and psoriasis arthritis"],"prefix":"10.1007","volume":"34","author":[{"given":"D.","family":"Windschall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,18]]},"reference":[{"issue":"4","key":"2744_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10067-009-1340-7","volume":"29","author":"M Atteno","year":"2010","unstructured":"Atteno M, Peluso R, Costa L et al (2010) Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. Clin Rheum 29(4):399\u2013403","journal-title":"Clin Rheum"},{"issue":"18","key":"2744_CR2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","volume":"346","author":"J Gorman","year":"2002","unstructured":"Gorman J, Sack K, Davis J (2002) Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor (alpha). N Engl J Med 346(18):1349\u20131356","journal-title":"N Engl J Med"},{"issue":"7","key":"2744_CR3","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/art.20335","volume":"50","author":"P Mease","year":"2004","unstructured":"Mease P, Kivitz A, Burch F, Siegel E et al (2004) Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 50(7):2264\u20132272","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2744_CR4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3899\/jrheum.091093","volume":"37","author":"P Mease","year":"2010","unstructured":"Mease P, Woolley JM, Singh A, Tsuji W, Dunn M, Chiou C (2010) Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. J Rheumatol 37(6):1221\u20131227","journal-title":"J Rheumatol"},{"issue":"3","key":"2744_CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaad.2003.10.507","volume":"50","author":"LA Wanke","year":"2004","unstructured":"Wanke LA, Mease P, Gottlieb A, Burge D (2004) Sustained improvement in activities of daily living and vitality in patients with psoriatic arthritis treated with etanercept. J Am Acad Derm 50(3):145","journal-title":"J Am Acad Derm"},{"issue":"6","key":"2744_CR6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0031-1287837","volume":"223","author":"G Dueckers","year":"2011","unstructured":"Dueckers G, Guellac N, Arbogast M et al (2011) Evidence and consensus based treatment guidelines 2010 for juvenile idiopathic arthritis by the German Society of Pediatric Rheumatology. Klin Padiatr 223(6):386\u2013394","journal-title":"Klin Padiatr"},{"issue":"9","key":"2744_CR7","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","volume":"60","author":"EH Giannini","year":"2009","unstructured":"Giannini EH, Ilowite NT, Lovell DJ et al (2009) Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum 60(9):2794\u20132804","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2744_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-009-0942-3","volume":"30","author":"M Halbig","year":"2009","unstructured":"Halbig M, Horneff G (2009) Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept. Rheumatol Int 30(2):229\u2013238","journal-title":"Rheumatol Int"},{"issue":"10","key":"2744_CR9","first-page":"2055","volume":"31","author":"M Henrickson","year":"2004","unstructured":"Henrickson M, Reiff A (2004) Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. J Rheumatol 31(10):2055\u20132061","journal-title":"J Rheumatol"},{"issue":"12","key":"2744_CR10","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"G Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T et al (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63(12):1638\u20131644","journal-title":"Ann Rheum Dis"},{"key":"2744_CR11","author":"G Horneff","year":"2013","unstructured":"Horneff G, Burgos-Vargas R, Constantin T et al (2013) Efficacy and safety of open label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: part 1(week 12) of the CLIPPER study. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2012-203046","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2744_CR12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.2007.087411","volume":"68","author":"FH Prince","year":"2009","unstructured":"Prince FH, Twilt M, ten Cate R et al (2009) Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis 68(5):635\u2013641","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 23","key":"2744_CR13","first-page":"71","volume":"19","author":"I Foeldvari","year":"2001","unstructured":"Foeldvari I, Ruperto N, Dressler F et al (2001) The German version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 19(4 Suppl 23):71\u201375","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"2744_CR14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658\u2013666","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2744_CR15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/rheumatology\/keq361","volume":"50","author":"G Horneff","year":"2011","unstructured":"Horneff G, Foeldvari I, Minden K, Moebius D, Hospach T (2011) Report on malignancies in the German juvenile idiopathic arthritis registry. Rheumatology (Oxford) 50(1):230\u2013236","journal-title":"Rheumatology (Oxford)"},{"key":"2744_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2431-12-29","volume":"12","author":"AR Kemper","year":"2012","unstructured":"Kemper AR, Van Mater H, Coeytaux R, Williams JW Jr, Sanders G (2012) Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis. BMC Pediatr 12:29","journal-title":"BMC Pediatr"},{"key":"2744_CR17","unstructured":"Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. Technology Appraisal No.35 National Institute for Health and Care Excellence. 1-24 March 2002 (review January 2005). www.nice.org.uk"},{"key":"2744_CR18","doi-asserted-by":"crossref","unstructured":"Lovell DJ, Giannini EH, Reiff A et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763\u2013769","DOI":"10.1056\/NEJM200003163421103"},{"issue":"5","key":"2744_CR19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2010.04.004","volume":"63","author":"A Paller","year":"2010","unstructured":"Paller A, Siegfried E, Eichenfield L et al (2010) Long-term etanercept in pediatric patients with plaque psoriasis. J Am Acad Derm 63(5):762\u2013768","journal-title":"J Am Acad Derm"},{"issue":"4","key":"2744_CR20","first-page":"349","volume":"66","author":"M Sticherling","year":"2007","unstructured":"Sticherling M, Minden K, K\u00fcster RM, Krause A, Borte M (2007) Psoriasis und Psoriasisarthritis im Kindes- und Jugendalter. Zeitschr Rheum 66(4):349\u2013354","journal-title":"Zeitschr Rheum"},{"issue":"7","key":"2744_CR21","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/art.21121","volume":"52","author":"S Tse","year":"2005","unstructured":"Tse S, Burgos-Vargas R, Laxer RM (2005) Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthritis Rheum 52(7):2103\u20132108","journal-title":"Arthritis Rheum"},{"key":"2744_CR22","doi-asserted-by":"crossref","unstructured":"Horneff G, Fitter S, Foeldvari I et al. Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. Arthritis Res Ther 2012 Oct 24;14(5):R230","DOI":"10.1186\/ar4072"},{"issue":"10","key":"2744_CR23","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.1780391013","volume":"39","author":"A Grom","year":"1996","unstructured":"Grom A, Murray KJ, Luyrink L et al (1996) Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum 39(10):1703\u20131710","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2744_CR24","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3899\/jrheum.110145","volume":"38","author":"MH Otten","year":"2011","unstructured":"Otten MH, Prince FH, Twilt M et al (2011) Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis\u2014data from the dutch arthritis and biologicals in children register, 1999-2010. J Rheumatol 38(10):2258\u20132263","journal-title":"J Rheumatol"},{"issue":"6","key":"2744_CR25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 46(6):1015\u20131019","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2744_CR26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0028-1086031","volume":"220","author":"S Winterhalter","year":"2008","unstructured":"Winterhalter S, Niehues T (2008) TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis?\u2014an evidence based approach. Klin Padiatr 220(6):342\u2013347","journal-title":"Klin Padiatr"},{"key":"2744_CR27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2006.08.044","volume":"149","author":"RK Saurenmann","year":"2006","unstructured":"Saurenmann RK, Levin V, Feldman BM, Laxer RM, Schneider R, Silverman ED (2006) Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNF\u03b1 agents. J Pediatr 149:833\u2013836","journal-title":"J Pediatr"},{"issue":"7","key":"2744_CR28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3899\/jrheum.100809","volume":"38","author":"TD Dijken van","year":"2011","unstructured":"van Dijken TD, Vastert SJ, Gerloni VM, Pontikaki I, Linnemann K, Girschick H, Armbrust W, Minden K, Prince FH, Kokke FT, Nieuwenhuis EE, Horneff G, Wulffraat NM (2011) Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept. J Rheumatol 38(7):1441\u20131446","journal-title":"J Rheumatol"},{"key":"2744_CR29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"A Klein","year":"2011","unstructured":"Klein A, Kaul I, Foeldvari I, Ganser G, Urban A, Horneff G (2011) Efficacy and safety of oral and parenteral methotrexate therapy in children with JIA: an observational study with patients from the German methotrexate registry. Arthritis Care Res 63:465\u2013482","journal-title":"Arthritis Care Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2744-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2744-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2744-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:36Z","timestamp":1559120256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2744-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,18]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2744-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,18]]}}}